SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022154
Filing Date
2019-11-08
Accepted
2019-11-08 16:06:59
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20190930_10q.htm 10-Q 1133190
2 EXHIBIT 31.1 ex_162662.htm EX-31.1 11354
3 EXHIBIT 31.2 ex_162663.htm EX-31.2 11560
4 EXHIBIT 32.1 ex_162664.htm EX-32.1 6237
5 EXHIBIT 32.2 ex_162665.htm EX-32.2 5899
  Complete submission text file 0001437749-19-022154.txt   4594324

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sphs-20190930.xml EX-101.INS 900238
7 XBRL TAXONOMY EXTENSION SCHEMA sphs-20190930.xsd EX-101.SCH 51271
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20190930_cal.xml EX-101.CAL 36427
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20190930_def.xml EX-101.DEF 314764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20190930_lab.xml EX-101.LAB 256145
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20190930_pre.xml EX-101.PRE 337822
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 191204106
SIC: 2834 Pharmaceutical Preparations